BioSpace News Archive

Univar Solutions tops the 10th ICIS Top 100 Chemical Distributors ranking in North America announced today.

Strategic Acquisition Diversifies Company’s Portfolio and Provides New Options for Migraine Patients

Dr. Reddy’s Laboratories Ltd. announces that it has entered into a definitive asset purchase agreement with Upsher-Smith Laboratories, LLC, pursuant to which Dr. Reddy’s would sell its US and select territory rights for ZEMBRACE® SYMTOUCH® 3 mg and TOSYMRA™ 10 mg, which are commercialized through its wholly owned subsidiary, Promius Pharma, LLC.

Over 71% of Patients Treated with ILUMYA™ Achieved ACR20 Response After 24 Weeks, with Significant Improvement as Early as 8 Weeks MUMB

Poster presented at 6th Global Forum on Nicotine, Warsaw, Poland

Study presented at 6th Global Forum on Nicotine contrasts exhaled toxicants in vapor products versus combustible cigarettes

Prometic Life Sciences Inc. announced that four abstracts highlighting Prometic’s progress in developing PBI-4050 as a potential treatment for both acute kidney injury and chronic kidney disease will be presented at the 56th Congress of the European Renal Association - European Dialysis and Transplant Association.

ArQule, Inc. announced preliminary results from the Company’s phase 1 dose escalation study for ARQ 531, an orally bioavailable, potent and reversible dual inhibitor of both wild type and C481S-mutant Bruton’s tyrosine kinase in patients with relapsed or refractory hematologic malignancies at the 2019 European Hematology Association Annual Meeting in Amsterdam, the Netherlands.

Flexible multi-channel digitizer with high channel density and open FPGA

Oncopeptides AB, announced new data presented at the 24th Congress of the European Hematology Association in Amsterdam, including updated interim data from the ongoing phase 1/2 ANCHOR study and data from its phase 1/2 O-12-M1 study.